LIPOCINE INC. Depreciation
LIPOCINE INC. (LPCN) reported Depreciation of $61.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-03-10
- LIPOCINE INC. depreciation for fiscal 2025 was $61.00K, a 48.78% increase from fiscal 2024.
- LIPOCINE INC. depreciation for fiscal 2024 was $41.00K, a 41.38% increase from fiscal 2023.
- LIPOCINE INC. depreciation for fiscal 2023 was $29.00K, a 205.26% increase from fiscal 2022.
- LIPOCINE INC. depreciation for fiscal 2022 was $9.50K, a 2275.00% increase from fiscal 2021.
| Period end | Depreciation 12 month |
|---|---|
| 2025-12-31 | $61.00K 10-K · filed 2026-03-10 |
| 2024-12-31 | $41.00K 10-K · filed 2026-03-10 |
| 2023-12-31 | $29.00K 10-K · filed 2025-03-13 |
| 2022-12-31 | $9.50K 10-K · filed 2024-03-07 |
| 2021-12-31 | $400.00 10-K · filed 2023-03-10 |
| 2020-12-31 | $4.00K 10-K · filed 2022-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |